Autoimmune Pathologies Associated with Lymphedema
Systemic sclerosis (scleroderma), systemic lupus erythematosus (SLE), and dermatomyositis are the primary autoimmune diseases that can cause or be associated with lymphedema, with systemic sclerosis being the most well-documented.
Primary Autoimmune Causes
Systemic Sclerosis (Scleroderma)
Systemic sclerosis demonstrates the strongest association with lymphedema among autoimmune diseases. Lymphatic involvement in SSc begins in early disease stages and results from the characteristic vascular abnormalities, immune activation, and fibrosis that define this condition 1. The lymphatic dysfunction can progress to clinically significant lymphedema, including grade 2 severity, even in limited cutaneous forms with anticentromere antibodies 1. The pathophysiology involves direct lymphatic vessel compromise from the fibrotic process inherent to scleroderma 2.
Systemic Lupus Erythematosus (SLE)
SLE can cause lymphedema through lymphatic obstruction, though this is uncommon 3. The mechanism involves immune-mediated lymphatic vessel damage, with documented cases showing obstruction affecting multiple extremities simultaneously 3. While rare, this represents a direct autoimmune-mediated lymphatic pathology 2.
Dermatomyositis
Dermatomyositis is recognized as having lymphatic dysfunction as part of its disease spectrum, though specific mechanisms relate to the inflammatory myopathy and associated vascular changes 2.
Autoimmune Diseases Occurring WITH Lymphedema
Autoimmune Thyroid Disease
Autoimmune hypothyroidism can occur in patients with congenital lymphedema, suggesting shared immune dysregulation 4. This association may reflect underlying immune system abnormalities rather than causation in either direction.
Celiac Disease
In Hennekam Syndrome (a genetic lymphatic disorder), celiac disease can develop as a secondary autoimmune complication 5. The proposed mechanism involves increased interstitial lymph fluid inducing TNF-α and IL-6-mediated immune reactions that trigger autoimmune pathologies in affected organs 5.
Checkpoint Inhibitor-Induced Autoimmunity
Cancer immunotherapy with checkpoint inhibitors can trigger various rheumatic immune-related adverse events, though lymphedema is not specifically highlighted as a primary manifestation 6. However, the guideline emphasizes that rheumatologists should provide facilitated access for assessment when rheumatic or systemic signs develop during immunotherapy 6.
Clinical Approach
When evaluating lymphedema for autoimmune etiology, specifically assess for:
- Skin thickening, Raynaud's phenomenon, and nailfold capillaroscopy changes suggesting systemic sclerosis 1
- Symmetric involvement and systemic lupus features (malar rash, serositis, cytopenias) 3
- Proximal muscle weakness suggesting dermatomyositis 2
- Autoantibodies: ANA, anticentromere, anti-Scl-70, anti-dsDNA, myositis-specific antibodies 1
Important Caveat
Lymphatic dysfunction in autoimmune diseases is bidirectional 2. The lymphatic system's role in immune tolerance means that lymphatic impairment may contribute to autoimmune disease pathophysiology, while autoimmune inflammation simultaneously damages lymphatic vessels, creating a self-perpetuating cycle 7.
Treatment of the underlying autoimmune disease (methotrexate, corticosteroids) combined with lymphatic drainage can improve lymphedema in these conditions 1.